Clinical Trial Update: GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

View source ↗

Summary

Completed clinical trial evaluating a GLP-1 receptor targeting approach in individuals with Type 1 Diabetes and in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor targeting agent (GLP-1 receptor agonist)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Type 1 Diabetes | Status: COMPLETED